Study of Anti-psoriatic activity and Evaluation of E2A Gene Expression for Psoriasis Levels by RT-PCR of Thespesia populnea L. Methanolic Leaf Extract
Keywords:
Thespesia populnea L., Anti-psoriatic activity, Phytoconsituents, Retion-A (0.05%)Abstract
Thespesia populnea L. (Malvaceae) traditionally claimed to be constructive in the cure of cutaneous infections such as scabies, psoriasis, ringworm, guinea worm, eczema and herpetic diseases. Oil prepared by boiling the ground bark and leaves in coconut oil is applied externally in psoriasis and scabies. Conversely there are no customary scientific reports for its anti-psoriatic activity. Hence the plant Thespesia populnea has been chosen to establish scientific data for its traditional claim as anti-psoriatic. In the present study a chemical test performed against all the phytochemical constituents for their preliminary screening of each solvent extract of leaf like water, methanol, chloroform, ethyl acetate, pet ether and acetone. From the phytochemical analysis of the leaf extracts; the result infers the presence of glycosides, tannins, flavonoids, triterpenoids and phytosterols in all the solvent extracts. But phenols are more retained in methanolic leaf extract compared to all the phytochemical constituents. Screening for anti-psoriatic activity was carried out by topical application of methanolic leaf extract of Thespesia populnea in the form of a cream using the Perry’s scientific mouse tail model. Successive methanolic leaf extract showed paramount anti-psoriatic activity than the standard drug Retion-A (0.05%). Potential function of E2A as a biomarker in psoriasis, is applied in the current investigation to study whether the methanolic leaf extracts of Thespesia populnea L. showed antipsoriatic effect targeting E2A gene expression for the psoriasis levels. Results indicated that methanolic leaf extract of Thespesia populnea can preferably be used as anti-psoriatic drug and the plant is promising for further investigations to prove its anti-psoriatic activity with no side effects.
Downloads
References
Akindele AJ, Adeyemi OO (2007) Anti inflammatory activity of the aqueous leaf extract of Byrsocarpuscoccineus. Fitoterapia 2007, 78(1):25-8.
Bjorntorp E, Parsa R, Thornemo M, Wennberg AM et al. (2003) The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin. Acta Derm. Venereol., 83: 403-409.
Chandran RP, Manju S, Shaji PK, Nair GA and Sukumar B (2016) In Vitro Cytotoxic Activities of Leaf Extracts of Thespesia populnea and HygrophillaSchulli Against Dalton’s Lymphoma Ascites and Ehrlich Ascites Carcino-ma Cell Lines. Austin J.Lung Cancer Res, 1(2): 1007.
Chikhali Umakant, Shankar Shinde, Amar Dinkar, Patil Sandip, Balvant Naikwade (2011) Evaluation of antitumor, antioxidant and cytotoxic activity of Thespesia populnea bark extract. Journal of Pharmacy Research, 4(10):3641
Engel I and Murre C (2001) The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1: 193- 199.
Karna P, Chagani S, Gundala SR, Rida PCG, Asif G, Sharma V, Gupta MV, Aneja R (2012) Benefits of whole ginger extract in prostate cancer. British Journal of Nutrition, 107(4):473–484.
Kee BL (2009) E and ID proteins branch out. Nat. Rev. Immunol., 9: 175-184.
Lindamulage IK, Soysa P (2016) Evaluation of anticancer properties of a decoction containing Adenanthera-pavonina L. and Thespesiapopulnea. BMC Complement Altern Med., 16:70
Liu RH (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. American Journal of Clinical Nutrition.78(3):517S–520S.
Mark EB, Jonsson M, Asp J, Wennberg AM et al. (2006) Expression of genes involved in the regulation of p16 in psoriatic involved skin. Arch.Dermatol.Res.,297:459-467.
Patwardhan B, Vaidhya ADB and Chorghade M (2004) Ayurveda and Naturalproducts drug discovery. Curr Sci., 86: 789-799.
Perk J, Iavarone A and Benezra R (2005) Id family of helix-loop-helix proteins in cancer. Nat.Rev.Cancer.5:603-614.
Pritam Kumar Panda, Danish Ibrahim, Pramod Kumar P. Gupta (2014) Computational modeling and analysis of theoretical structure of corneodesmosin receptor protein with existing phytochemicals in psoriasis, Indian J. of Fund. and Applied Life Sciences.2014, 4 (4), 346-355.
Parthasarathy R, Ilavarasan R, Karrunakaran CM (2009) Antidiabetic activity of ThespesiaPopulnea bark and leaf extract against streptozotocin induced diabetic rats. International J. of Pharm.Tech Research. 2009.
Samuel ML, Donald PM, Hurley JH Jr (1986) Dermatology Vol-I. W. B. Philadelphia:SaundersCompany; p.204.
Sandhya T, Lathika KM, Pandey BN, Mishra KP (2006) Potential of ayurvedic formulation, Triphala, as novel anticancer drug. Cancer letters, 231(2): 206-214.
Satyavati GV, Gupta AK, Tandon N (1987) Medicinal Plants of India. ICMR, New Delhi, India.
Siddharth Shrivastav, Rakesh K. Sindhu, Sanjeev Kumar, Pradeep Kumar (2009) Anti-Psoriatic And Phytoche-mical Evaluation Of Thespesia Populnea Bark Extracts. Int J Pharm Pharm Sci.
Si-Yuan Pan, Gerhard Litscher, Si-HuaGao, Shu-Feng Zhou, Zhi-Ling Yu, Hou-Qi Chen, Shuo-Feng Zhang, Min-Ke Tang, Jian-Ning Sun, and Kam-Ming Ko. Historical
Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources. Evidence-Based Complementary and Alternative Medicine. 2014.
Walter LF, Gundula S (1981) Histopathology of the skin. 3rd Edn., Boston, Massachusetts: Lippincott;p.156-64.
Yogayata S Pathare, Vijay D Wagh(2012) Herbal Medicines and Nutritional supplements used in the treatment of Glaucoma: A Review. RJPBCS, Volume 3 Issue 1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Authors

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/